ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Philadelphia, PA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Diabetes Mellitus
Type 2 Diabetes Mellitus
Type 1 Diabetes Mellitus
Diabetic Foot
Foot Ulcer
Obesity
Ulcer

Diabetes trials near Philadelphia, PA, USA:

Teplizumab in Pediatric Stage 2 Type 1 Diabetes (PETITE-T1D)

The purpose of this study is to assess the safety and pharmacokinetics (PK) of teplizumab in participants with Stage 2 type 1 diabetes who a...

Active, not recruiting
Diabetes Mellitus, Type 1
Biological: teplizumab

Phase 4

Provention Bio, a Sanofi Company

Philadelphia, Pennsylvania, United States and 9 other locations

Objectives The objective of this clinical trial is to assess whether ladarixin treatment has an effect to preserve β-cell function and delay the prog...

Active, not recruiting
Recent Onset type1 Diabetes
Drug: Placebo
Drug: Ladarixin

Phase 2

Dompé
Dompé

Philadelphia, Pennsylvania, United States and 56 other locations

This study will evaluate the safety, efficacy and durability of SR-02 administered to the omentum of patients of Type 1 diabetes with severe...

Not yet enrolling
Diabetes Mellitus Type 1
Biological: Allogeneic Pancreatic Endocrine Cell Clusters

Phase 1, Phase 2

Seraxis

Philadelphia, Pennsylvania, United States and 1 other location

This study aims to investigate the efficacy and safety of tirzepatide in participants with type 2 diabetes (T2D) compared to other existing ...

Active, not recruiting
Type 2 Diabetes
Drug: Antihyperglycemic medication
Drug: Tirzepatide

Phase 4

Lilly
Lilly

Philadelphia, Pennsylvania, United States and 89 other locations

Locations recently updated

This study will look at the long-term effects of semaglutide (active medicine) on diabetic eye disease when compared to placebo (dummy medic...

Active, not recruiting
Diabetes Mellitus, Type 2
Drug: Semaglutide
Drug: Placebo (semaglutide)

Phase 3

Novo Nordisk
Novo Nordisk

Philadelphia, Pennsylvania, United States and 177 other locations

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increas...

Active, not recruiting
Type 2 Diabetes Mellitus
Drug: Tirzepatide
Drug: Dulaglutide

Phase 3

Lilly
Lilly

Philadelphia, Pennsylvania, United States and 654 other locations

The purpose of the study is to evaluate the safety, tolerability, and efficacy of VX-264 in participants with type 1 diabetes (T1D)....

Enrolling
Type 1 Diabetes
Drug: VX-264

Phase 1, Phase 2

Vertex Pharmaceuticals
Vertex Pharmaceuticals

Philadelphia, Pennsylvania, United States and 15 other locations

The purpose of this study is to find out how well a new continuous glucose monitor works for people with diabetes. This study will test the ....

Begins enrollment in 2 months
Type 1 Diabetes Mellitus
Type 2 Diabetes Mellitus
Device: Continuous Glucose Monitoring
Medtronic
Medtronic

Philadelphia, Pennsylvania, United States and 27 other locations

it takes the body to remove it in pediatric participants with Type 2 Diabetes Mellitus (T2DM). The study will last for approximately 100 day...

Enrolling
Type 2 Diabetes Mellitus
Drug: LY3209590

Phase 1

Lilly
Lilly

Philadelphia, Pennsylvania, United States and 11 other locations

Locations recently updated

double-blind, parallel-group, placebo-controlled study to evaluate the efficacy, safety and tolerability of AZD5004 in adults with type 2 diabetes...

Enrolling
Diabetes Mellitus, Type 2
Drug: AZD5004
Drug: Placebo (placebo matching AZD5004 film-coated tablet)

Phase 2

AstraZeneca
AstraZeneca

West Chester, Pennsylvania, United States and 117 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems